RBI Local Area Bank Shareholding Rules 2026 - Tax Impact

What Happened?

The Reserve Bank of India has announced a significant amendment to Local Area Bank (LAB) shareholding rules effective October 2026. The new framework permits one-time approval for subsequent major share acquisitions by qualifying institutional investors — specifically mutual funds, insurance companies, and pension funds. This replaces the earlier requirement of seeking approval for each individual transaction, streamlining the investment process significantly.

Background & Legal Context

Before understanding the tax implications, let us first understand what triggered this change and which laws apply to you.

What are Local Area Banks?

Local Area Banks (LABs) are scheduled commercial banks permitted to operate only within a defined geographical area. They are regulated under the Banking Regulation Act, 1949 and RBI guidelines. LABs were introduced to promote financial inclusion in tier-2 and tier-3 cities.

Previous Shareholding Rules

Under the earlier framework, any investor wanting to acquire a "major shareholding" (typically 5% or more, or any acquisition beyond a specified threshold) in a LAB required RBI prior approval for each transaction. This created compliance delays and discouraged institutional investment in LABs.

Tax Laws That Apply

When you invest in LAB shares, multiple tax provisions of the Income Tax Act, 2025 apply to you:

• Section 48 (Capital Gains) — If you sell LAB shares, you trigger capital gains tax. The gain is calculated as sale price minus cost of acquisition and indexed cost.
• Section 55 (Cost of Acquisition) — Your original investment amount in LAB shares is the base. Under the new approval mechanism, ensure you maintain proper documentation of acquisition costs.
• Section 112 (Long-term Capital Gains Tax) — If held for more than 24 months (for listed securities), gains taxed at 20% with indexation benefit. Relevant for AY 2025-26 and AY 2026-27 onwards.
• Section 115BAA (Corporate Tax Option) — If you are a company holding LAB shares, you may have the option to opt for the lower corporate tax rate of 15% under certain conditions.
• Section 194LA (TDS on Sale of Securities) — When you sell LAB shares through a broker, TDS may be triggered if gains exceed applicable thresholds.
• Section 139(1) (ITR Filing) — All investors earning income from LAB shares or dividends must file ITR regularly for AY 2025-26 and onwards.

GST Implication

Investment in shares and securities is exempt from GST under Schedule III of the CGST Act, 2017. This exemption applies to LAB shares as well. However, brokerage charges or advisory fees paid for acquiring LAB shares may attract 18% GST.

What Does This Mean for You?

The RBI's one-time approval framework has several practical implications:

For Mutual Funds Investing in LABs

• Mutual funds can now acquire major stakes in multiple LABs without repeated RBI approvals, as long as they have obtained one-time approval from RBI.
• When a mutual fund holds LAB shares, dividend income is taxed in the hands of the fund (corporate rate) and then distributed to unit holders as dividends.
• Unit holders receiving dividend income must file ITR for AY 2025-26+ if dividend exceeds filing threshold.
• Long-term capital gains earned by the mutual fund on sale of LAB shares are taxed at 20% with indexation (Section 112) when distributed to unit holders holding units for 24+ months.

For Insurance Companies Investing in LABs

• Insurance companies now have streamlined approval process for strategic shareholding in LABs.
• Dividend and interest income from LAB investments are taxed as per normal corporate tax rules under the Income Tax Act, 2025.
• Insurance companies must maintain separate reserve accounts as per regulatory norms. Interest on reserves is tax-deductible under Section 36(1)(viii).
• When selling LAB shares, capital gains tax applies. Since insurance companies typically hold for long-term, Section 112 (20% LTCG tax) applies if holding period exceeds 24 months.

For Pension Funds & Sovereign Wealth Funds

• These entities enjoy special tax treatment under the Income Tax Act, 2025. Many pension funds are exempt entities under Section 10.
• However, profits and gains from share investments in LABs may not be fully exempt. Consult with a tax advisor on your specific entity's exemption status.
• Capital gains on LAB shares held by pension funds may trigger tax liability depending on the fund's status.

For Individual Investors Holding LAB Shares

• If you hold LAB shares as an individual, any dividend received is taxable income under Section 56(2)(vi) read with Schedule 6 (Dividend Slabs).
• Dividend income for AY 2025-26 is taxed at slab rates (5%, 10%, 15%, 20%, 30%) depending on total income.
• When you sell LAB shares, capital gains apply. LTCG tax is 20% with indexation if held 24+ months; STCG is added to income slab.
• The streamlined approval process does NOT directly affect your personal tax; however, it improves market liquidity, which may increase share values.

What Should You Do Now?

1. Review Your LAB Share Holdings

If you hold LAB shares (directly or through mutual funds/insurance policies), obtain a summary of:

• Cost of acquisition (for Section 55 calculations)
• Date of acquisition (to determine LTCG/STCG status)
• Dividend received in FY 2024-25 and FY 2025-26
• Current market value (for reporting in ITR)

2. Maintain Proper Documentation

Keep records of:

• Share certificates or demat statements
• Dividend statements showing TDS deducted (if any)
• Broker statements for acquisitions and sales
• Bank statements showing dividend credit

3. File ITR for FY 2025-26 (AY 2026-27)

If you earned any income from LAB shares (dividend or capital gains), file ITR on time using:

• ITR-1 (if income from salary + LAB dividend/gains, total income under ₹50 lakhs)
• ITR-2 (for all individuals with capital gains)
• ITR-4 (if you are a professional with LAB share income)

4. Plan Your Exits (Sale of LAB Shares)

If you intend to sell LAB shares before AY 2026-27 begins (i.e., before 1 April 2026):

• Check if you have held shares for 24+ months (to qualify for LTCG tax at 20% with indexation)
• If STCG applies, plan to offset gains with losses from other investments (Section 70 & 71)
• Ensure TDS is deducted by broker; claim credit in ITR

5. Consult a Tax Advisor

If you are a:

• High Net Worth Individual (HNI) with substantial LAB holdings
• Mutual fund or insurance company seeking to increase LAB stake
• Foreign investor in LAB shares (complex FEMA + tax rules apply)

...consult with a Chartered Accountant for personalized advice on the new rules and optimal tax strategy.

Key Takeaways

• RBI's One-Time Approval: Qualifying mutual funds, insurers, and pension funds can now acquire major shareholdings in LABs with a single RBI approval for all future acquisitions, eliminating repeat approvals.
• Tax Implications Unchanged: The new approval mechanism does not alter existing Income Tax Act, 2025 provisions. LTCG (20% with indexation), STCG (slab rates), and dividend tax rules continue to apply.
• Section 112 Benefits: Investors holding LAB shares for 24+ months enjoy capital gains tax at 20% with indexation benefit under Section 112 of the Income Tax Act, 2025 — a significant advantage for long-term investors.
• Documentation is Critical: With increased LAB share transactions expected post-amendment, maintain proper acquisition cost records and dated certificates to substantiate Section 55 cost basis for ITR filing in AY 2026-27 onwards.
• GST Exemption on Shares: Investment in LAB shares is GST-exempt, but advisory/brokerage fees attract 18% GST. Budget accordingly when acquiring or selling LAB shares.

Need expert help with this? EaseValue CAs in Jaipur — WhatsApp 63677 44602